Groupe Bruxelles Lambert (ENXTBR:GBLB) just reported nine month 2026 results that swung from a net loss a year ago to net income of €28.6 million, supported by €5,117.6 million in sales.
Groupe Bruxelles Lambert shares trade at €79.05 after a 30 day share price return of 14.98%. That rebound comes on top of a 15.28% 1 year total shareholder return, while the 5 year total shareholder return remains down 9.08%, so recent momentum is building from a relatively weak longer run base.
Compare Groupe Bruxelles Lambert's rebound with other listed investment firms by reviewing our curated list of list of solid balance sheet and fundamentals (190 results).
Groupe Bruxelles Lambert has just jumped on fresh earnings, yet the share price still sits below the average analyst target and any intrinsic estimates. The real tension is whether that gap reflects opportunity or lingering risk.
Preferred Multiple of 1.4x P/S: Is it justified?
On the latest numbers, Groupe Bruxelles Lambert trades on a P/S of 1.4x, which sits well below peers even after the share price recovery to €79.05. That gap to both local and broader European diversified financial groups is where the valuation debate really shows up.
The P/S ratio compares the market value of the equity to the revenue the business generates each year. For an investment holding group like Groupe Bruxelles Lambert, this focuses attention on how much investors are paying for each euro of consolidated sales rather than near term earnings, which are still in loss territory and can be choppy.
Against that backdrop, the numbers indicate a relatively cheaper tag. Management is still working through an unprofitable period, yet the stock is priced at 1.4x sales compared to a peer average of 7.3x and a European diversified financial industry average of 2.2x. That is a wide discount, and if market confidence in future profitability improves, the multiple could move closer to those reference points.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-sales of 1.4x (UNDERVALUED)
Still, the ongoing net loss of €277.1 million and the relatively modest 2.9% annual revenue growth leave room for potential setbacks in the Groupe Bruxelles Lambert story.
Find out about the key risks to this Groupe Bruxelles Lambert narrative.
Next Steps
Mixed signals in the Groupe Bruxelles Lambert story so far. Use the full dataset, move quickly while sentiment is split, and weigh the 1 key reward and 1 important warning sign.
Looking for more investment ideas beyond Groupe Bruxelles Lambert?
If you stop with Groupe Bruxelles Lambert, you risk missing opportunities that better match your goals, risk comfort, and timeline across different corners of the market.
- Target potential mispricing by scanning a focused set of 221 high quality undervalued stocks that combine stronger fundamentals with more conservative valuations.
- Strengthen the income side of your portfolio by reviewing a curated group of 229 dividend fortresses that aim to provide reliable cash returns.
- Reduce overall portfolio stress by filtering for 209 resilient stocks with low risk scores designed to keep balance sheets and volatility on a tighter leash.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com